Cleft Palate
Conditions
Interventions
Group R:0.33% Ropivocaine combined with Epinephrine 1:200,000 was used for infiltration
Group L:1% Lidocaine combined with Epinephrine 1:200,000 was used for infiltration
Sponsors
Guangzhou Women and Children's Medical Center
Eligibility
Sex/Gender
All
Age
0.5 Years to 3 Years
Inclusion criteria
Inclusion criteria: Children scheduled for palate repair, aged from 6 months to 3 years, American Society of Anesthesiologists physical status I or II, were eligible for the present study.
Exclusion criteria
Exclusion criteria: (1) children with diseases of respiratory, cardiovascular, hepatic or renal system; (2) allergy to ropivacaine or lidocaine; (3) difficult airway requiring postoperative ventilator support; (4) coagulation disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FLACC score; | — |
Secondary
| Measure | Time frame |
|---|---|
| FLACC score;consumption of flurbiprofen axetil;consumpution of hydromorphone;mean arterial pressure;systolic blood pressure;diatolic blood pressure;heart rate;saturation of pulse oximetry;adverse reactions after surgery (nausea and vomiting, pruritus);demographic data (age, weight, gender);operation related index (operation type, operating time);anesthesia related index(anesthesia time, consumption of regional anesthetic);press numbers of postoperative analgesia pump (effrective, ineffective); | — |
Countries
China
Contacts
Public ContactGaofeng Yu
Guangzhou Women and Children's Medical Center
Outcome results
None listed